BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11534508)

  • 1. Atrophoderma and juvenile idiopathic arthritis.
    Ramanan AV; Baildam EM; Judge MR
    Ann Rheum Dis; 2001 Sep; 60(9):900-1. PubMed ID: 11534508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biologic agents in juvenile idiopathic arthritis].
    Gomes JA
    Acta Reumatol Port; 2007; 32(1):13-4. PubMed ID: 17450760
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis.
    Dyer JA; Guitart J; Klein-Gitelman M; Mancini AJ
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S65-8. PubMed ID: 17938028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate.
    Londino AV; Blatt J; Knisely AS
    J Rheumatol; 1998 Jun; 25(6):1245-6. PubMed ID: 9632099
    [No Abstract]   [Full Text] [Related]  

  • 5. Overlap between atrophoderma Pasini-Pierini and juvenile idiopathic arthritis.
    Kim YS; Lee CW
    Clin Exp Dermatol; 2009 Jan; 34(1):82-3. PubMed ID: 19076797
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate in juvenile idiopathic arthritis: answers and questions.
    Ravelli A; Martini A
    J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Good help from modern treatment of juvenile idiopathic arthritis].
    Berntson L; Hagelberg S; Månsson B; Fasth A
    Lakartidningen; 2013 Apr 10-16; 110(15):754-7. PubMed ID: 23662535
    [No Abstract]   [Full Text] [Related]  

  • 9. Coexistent sickle cell disease and juvenile rheumatoid arthritis: 2 cases with delayed diagnosis and severe destructive arthropathy.
    Eberhard BA
    J Rheumatol; 2002 Aug; 29(8):1802; author reply 1802-3. PubMed ID: 12180751
    [No Abstract]   [Full Text] [Related]  

  • 10. Celiac disease and juvenile idiopathic arthritis: a still enigmatic crossover.
    De Maddi F; Pellegrini F; Raffaele CG; Tarantino G; Rigante D
    Scand J Gastroenterol; 2013 Apr; 48(4):511-2. PubMed ID: 23448357
    [No Abstract]   [Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
    Barr T; Carmichael NM; Sándor GK
    J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in juvenile idiopathic arthritis: a preliminary report.
    Bernatsky S; Rosenberg AM; Oen KG; Duffy CM; Ramsey-Goldman R; Labrecque J; St Pierre Y; Clarke AE
    J Rheumatol; 2011 Apr; 38(4):760-3. PubMed ID: 21239753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis].
    Tambić-Bukovac L; Malcić I; Prohić A
    Reumatizam; 2002; 49(1):20-4. PubMed ID: 12476749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary haemosiderosis with juvenile idiopathic arthritis in a Malaysian child.
    Wong AR; Noor AS; Rasool AH; Quah BS; Roberton D
    Med J Malaysia; 2007 Oct; 62(4):352-4. PubMed ID: 18551948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Juvenile Still's disease: a case report of treatment with infliximab].
    Meddeb N; Rammeh N; Gandoura N; Elleuch M; Cheour E; Sahli H; Hamza S; Maalej A; Sellami S
    Therapie; 2002; 57(4):407-8. PubMed ID: 12422562
    [No Abstract]   [Full Text] [Related]  

  • 16. [Accelerated nodulosis during methotrexate therapy for idiopathic juvenile arthritis].
    Paúl A; Estanqueiro P; Salgado M
    Acta Reumatol Port; 2011; 36(1):83-4. PubMed ID: 21483289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Juvenile idiopathic arthritis].
    Herlin T
    Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
    Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
    Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
    Chan AY; Liu DT
    J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.